• BRD4–RAC1 Co-targeting in Breast Cancer

  2026-08-15

  The reference study shows that simultaneous inhibition of BRD4 and RAC1 suppresses breast cancer growth, migration, stem-like behavior, and tumorigenesis across molecular subtypes. Its mechanistic contribution is the identification of a c-MYC–G9a–FTH1 axis and HDAC1-associated chromatin changes that connect epigenetic and small-GTPase signaling.

• X-Gal: From Clone Selection to Assay Logic

  2026-08-14

  X-Gal is more than a blue-white screening reagent: it illustrates how enzymatic reporters convert molecular events into interpretable phenotypes. This guide connects X-Gal chemistry, molecular cloning decisions, and the assay-design lessons of an iRhom2 olfaction study.

• Geneticin Beyond Selection: A Translational Playbook

  2026-08-14

  Geneticin, also known as G-418 Sulfate, is more than a routine selection reagent. Its ribosome-directed pressure can be used to build cleaner engineered cell systems, while its reported activity in DENV-2 assays creates a measured bridge to antiviral research. This article connects mechanism, assay design, transporter-aware interpretation, and translational strategy without overstating what current evidence proves.

• NSC-23766: Mapping Rac1 in Phagocytosis

  2026-08-13

  Explore NSC-23766 as a Rac GTPase inhibitor for separating Rac1-dependent cytoskeletal events from upstream CD47–Vav signaling, with practical guidance for phagocytosis and cancer research assays.

• Hyperthermia Sensitizes BRCA2-Proficient Ovarian Cancer

  2026-08-13

  Mei et al. show that hyperthermia can reduce BRCA2 protein and increase niraparib sensitivity in ovarian carcinoma cells that retain BRCA2 function. The study links thermal treatment to impaired RAD51 focus formation, enhanced apoptosis, and improved tumor control in an ID8 mouse model, providing a rationale for combination strategies beyond genetically BRCA-deficient disease.

• FITC-Concanavalin A (ConA) Conjugate Guide

  2026-08-12

  FITC-Concanavalin A (ConA) Conjugate provides direct fluorescent detection of α-D-glucose and α-D-mannose residues on cell surfaces, supporting immunofluorescence staining, flow cytometry, and glycobiology workflows. It should be used as a carbohydrate-binding probe rather than as a general cell-surface marker, and it requires protected, refrigerated storage.

• Phosbind Biotin for Phosphorylation Workflows

  2026-08-12

  Phosbind Biotin enables sequence-independent Western Blot detection of phosphorylated proteins when suitable phospho-specific antibodies are unavailable. This workflow-focused guide shows how to optimize dinuclear metal complex phosphate binding for plant stress studies, signaling research, and comparative phosphorylation analysis.

• BMS-345541: Practical IKK-1/IKK-2 Workflows

  2026-08-11

  BMS-345541 is a selective IKK-1/IKK-2 inhibitor for connecting NF-κB activity with cytokine release, angiogenesis, and cancer-cell responses. This workflow-focused guide shows how to build concentration screens, choose orthogonal readouts, and troubleshoot solubility, toxicity, and pathway-specificity issues.

• Protease Inhibitor Cocktail for LAG-3 Assays

  2026-08-11

  Protect LAG-3–TCR complexes, CD3ε/Lck associations, and phosphorylation-sensitive samples during extraction with an EDTA-free, broad-spectrum formulation. This workflow-focused guide shows how to apply the cocktail to Western blotting, co-immunoprecipitation, kinase assays, and microscopy-oriented sample preparation.

• Neticonazole Hydrochloride: Research Workflows

  2026-08-10

  Neticonazole Hydrochloride supports two distinct laboratory use cases: membrane-targeted antifungal experiments and exploratory colorectal cancer research focused on exosome release and apoptosis. This guide connects practical handling, assay design, delivery-platform evaluation, and troubleshooting without treating preliminary oncology findings as clinical evidence.

• BPN-19186 in sEH–Nrf2 Research Workflows

  2026-08-09

  BPN-19186 offers a practical chemical-probe framework for connecting soluble epoxide hydrolase activity with Nrf2-linked redox phenotypes. This guide translates the liver–bone findings into staged biochemical, metabolite, and osteoclast assays while emphasizing solubility, vehicle control, and mechanistic validation.

• Diclofenac in Human Intestinal Organoids

  2026-08-08

  Explore how Diclofenac can be evaluated in hiPSC-derived intestinal organoids through a staged framework that separates intestinal exposure, metabolism, and COX-linked pharmacodynamics. This practical perspective extends current organoid pharmacokinetic research into better-controlled inflammation and pain signaling studies.

• Protease Inhibitor Cocktail for T Cell Assays

  2026-08-07

  The Protease Inhibitor Cocktail protects fragile signaling proteins during extraction, Western blotting, co-immunoprecipitation, and kinase workflows. Its EDTA-free, 100X DMSO formulation is particularly useful when divalent cations, phosphorylation states, or native protein complexes must remain intact.

• S-Adenosylhomocysteine: Applied Workflows & Troubleshooting

  2026-08-07

  S-Adenosylhomocysteine (SAH) is an indispensable tool for dissecting methylation dynamics, metabolic feedback, and disease-relevant enzyme regulation. This guide delivers actionable workflows, key troubleshooting strategies, and direct translation of cutting-edge findings—empowering researchers to optimize methyltransferase inhibition and homocysteine metabolism assays.

• Arachidonic Acid Supplementation Accelerates Vaccine-Induced

  2026-08-06

  This study demonstrates that dietary arachidonic acid (ARA) significantly enhances the speed and magnitude of vaccine-induced humoral immunity in both mice and human subjects. By elucidating the mechanism—ARA-derived prostaglandin I2 acting via the cAMP-PKA pathway to boost B cell activation—the paper suggests new avenues for dietary modulation of vaccine efficacy.

537 records 7/36 page Previous Next First page 上5页 678910 下5页 Last page